Making an easy transition to multifocal IOLs

Article

We report from a unique OTEurope and Carl Zeiss Meditec breakfast meeting looking at how easy it is to integrate multifocal IOLs into your practice. The session also included patients who told doctors about their personal experience.

Carl Zeiss Meditec, in conjunction with Ophthalmology Times Europe, recently surveyed cataract and refractive surgeons across Europe to ascertain their attitudes towards multifocal IOLs. The results were revealed at a live event on the second morning of the ESCRS, attended by over 50 delegates.

Moderating the session was Dr Patrick Versace from Australia who also spoke about the expectations of the patient and the surgeon. He informed the audience that even though it had been found in a separate survey that patients would choose multifocal IOLs given the option, the OTEurope survey found that surgeons were reluctant to offer them because of their fears regarding patient dissatisfaction.

Dr Roberto Zaldivar continued the discussion looking at what both parties want from multifocal IOLs and Dr Dandapani Ramamurthy addressed the issues around aberration correction/rotational stability, centration, pupil independence and range of refraction. Halos and glare after surgery, was the topic of Dr Roger Zaldivar's presentation.

At this point it was clear that management of the patient's expectations is a critically important factor in obtaining a good response post-op. Dr Johannes Weisensee covered this and invited two of his patients to share their experiences with the session. The patients, Mrs Madeleine Kaiser and Mr Peter Wehner, had both suffered from myopia and presbyopia and they offered an insight into how they felt going into an operation and the consequences afterwards. "I have suffered with poor eyesight all my life and when the opportunity to undergo clear lens extraction was explained to me I jumped at it," explained Mrs Kaiser. "It is the best decision I have ever made." Despite continuing to experience halos, difficulty in reading in low light she now has excellent distance vision, no other problems reading and her quality of life has improved phenomenally.

In summing up Dr Versace remarked on the costs associated with introducing multifocal lenses into a practice. "There is really no specific cost in introducing multifocal IOLs into your practice, but what I would ask is whether as doctors we can afford not to by way of losing patients."

A more detailed look at the event will appear in OTEurope's November issue.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.